Qritive Recognized in Japan Smart Healthy Aging QuickFire Challenge

Singapore, July 1, 2025 — Qritive is proud to be selected as an awardee of the Japan Smart Healthy Aging QuickFire Challenge, an initiative by Johnson & Johnson Innovation to support breakthrough healthcare solutions focused on increasing healthy life expectancy in Japan.

This recognition reflects Qritive’s ongoing mission to drive impact through AI-powered diagnostics that enable earlier detection, faster reporting, and improved decision-making in clinical workflows. Our digital pathology solutions are designed to support healthcare systems facing the challenges of aging populations—enhancing efficiency, accuracy, and accessibility across diagnostic practices.

As Japan continues to prioritize innovation in healthcare and healthy aging, Qritive is excited to contribute with scalable, clinically validated AI diagnostics that align with national and global health goals.

We are honored to be part of this challenge and look forward to further collaboration that supports smart, sustainable advancements in digital pathology and healthy aging.

Learn more about the Japan Smart Healthy Aging QuickFire Challenge

About Qritive

Headquartered in Singapore, with operations in the US and India, Qritive is a breakthrough Artificial Intelligence (AI) solution developer that is advancing digital pathology for cancer diagnosis and improving health outcomes. Qritive leverages deep learning technology to support the interpretation of pathology tests for time and resource-strapped pathologists, enabling faster diagnosis and reducing time to treatment for patients. Qritive is dedicated to empowering healthcare professionals across the globe with AI-powered solutions to operate collaboratively at the peak of their performance despite complexity and distance. 

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com